BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12877580)

  • 1. Synthesis and potent antileukemic activities of N-lactylsphingosine and N-lactyldihydrosphingosine.
    Azuma H; Takao R; Shikata K; Niiro H; Tachibana T; Ogino K
    J Med Chem; 2003 Jul; 46(16):3445-7. PubMed ID: 12877580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total syntheses of symbioramide derivatives from l-serine and their antileukemic activities.
    Azuma H; Takao R; Niiro H; Shikata K; Tamagaki S; Tachibana T; Ogino K
    J Org Chem; 2003 Apr; 68(7):2790-7. PubMed ID: 12662053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and growth inhibitory activity of chiral 5-hydroxy-2-N-acyl-(3E)-sphingenines: ceramides with an unusual sphingoid backbone.
    Chun J; Byun HS; Arthur G; Bittman R
    J Org Chem; 2003 Jan; 68(2):355-9. PubMed ID: 12530860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible, polymer-supported synthesis of sphingosine derivatives provides ceramides with enhanced biological activity.
    El-Dahshan A; Al-Gharabli SI; Radetzki S; Al-Tel TH; Kumar P; Rademann J
    Bioorg Med Chem; 2014 Oct; 22(19):5506-12. PubMed ID: 25172146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 7-oxasphingosine and -ceramide analogues and their evaluation in a model for apoptosis.
    Rajan R; Wallimann K; Vasella A; Pace D; Genazzani AA; Canonico PL; Condorelli F
    Chem Biodivers; 2004 Nov; 1(11):1785-99. PubMed ID: 17191816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of constrained ceramide analogs and their potent antileukemic activities.
    Ha HJ; Hong MC; Ko SW; Kim YW; Lee WK; Park J
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1880-3. PubMed ID: 16455244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Disubstituted oxazolidin-2-ones as constrained ceramide analogs with anticancer activities.
    Singh A; Ha HJ; Park J; Kim JH; Lee WK
    Bioorg Med Chem; 2011 Nov; 19(21):6174-81. PubMed ID: 21978949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological properties of novel sphingosine derivatives.
    Murakami T; Furusawa K; Tamai T; Yoshikai K; Nishikawa M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1115-9. PubMed ID: 15686924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer.
    Antoon JW; Beckman BS
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2624-8. PubMed ID: 22366655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of non-natural C2-homo-ceramide and its apoptotic activity against HL-60 cells.
    Shikata K; Niiro H; Azuma H; Tachibana T; Ogino K
    Bioorg Med Chem Lett; 2003 Feb; 13(4):613-6. PubMed ID: 12639542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.
    Antoon JW; Liu J; Gestaut MM; Burow ME; Beckman BS; Foroozesh M
    J Med Chem; 2009 Sep; 52(18):5748-52. PubMed ID: 19694470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (3Z)-2-Acetylamino-3-octadecen-1-ol as a potent apoptotic agent against HL-60 cells.
    Niiro H; Azuma H; Tanago S; Matsumura K; Shikata K; Tachibana T; Ogino K
    Bioorg Med Chem; 2004 Jan; 12(1):45-51. PubMed ID: 14697769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.
    Johnson CR; Chun J; Bittman R; Jarvis WD
    J Pharmacol Exp Ther; 2004 May; 309(2):452-61. PubMed ID: 14724218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic activities of C2-ceramide and C2-dihydroceramide homologues against HL-60 cells.
    Shikata K; Niiro H; Azuma H; Ogino K; Tachibana T
    Bioorg Med Chem; 2003 Jul; 11(13):2723-8. PubMed ID: 12788346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective synthesis of jaspine B from D-xylose.
    Liu J; Du Y; Dong X; Meng S; Xiao J; Cheng L
    Carbohydr Res; 2006 Nov; 341(16):2653-7. PubMed ID: 16973139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First asymmetric synthesis of 6-hydroxy-4-sphingenine-containing ceramides. Use of chiral propargylic alcohols to prepare a lipid found in human skin.
    Chun J; Byun HS; Bittman R
    J Org Chem; 2003 Jan; 68(2):348-54. PubMed ID: 12530859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient, one-pot synthesis of various ceramide 1-phosphates from sphingosine 1-phosphate.
    Nussbaumer P; Hornillos V; Ghobrial M; Ullrich T
    Chem Phys Lipids; 2008 Feb; 151(2):125-8. PubMed ID: 18039471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
    Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
    Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a trans configuration for the apoptosis-inducing activity of ceramide.
    Kishida E; Kasahara M; Takagi Y; Matsumura M; Hayashi T; Kobayashi S; Masuzawa Y
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):127-37. PubMed ID: 9246602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.